Bavarian Nordic Moves to Expand Mpox Vaccine Use t...
Category : Clinical Trial Update 30 March 2026Bavarian Nordic has taken a significant regulatory step by submitting clinical data to the European...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
AstraZeneca’s Tozorakimab Shows Strong Phase III R...
Category : Clinical Trial Update 30 March 2026AstraZeneca has reported positive Phase III results for its investigational biologic tozorakimab, of...
GSK’s Bepirovirsen Moves Closer to Approval for Ch...
Category : Clinical Trial Update 30 March 2026GSK plc has taken a key regulatory step as the European Medicines Agency (EMA) accepted its marketin...
A First-in-Class Approach to Endometriosis Pain: W...
Category : Clinical Trial Update 27 March 2026Endometriosis treatment has barely evolved in decades. Most therapies suppress hormones. That works&...
Reinventing a 90-Year-Old TB Test: Can Needle-Free...
Category : Clinical Trial Update 27 March 2026Tuberculosis testing hasn’t changed much in nearly a century.That might finally be about to&nb...
Latest Newsletter Post
-
GSK’s Bepirovirsen Moves Closer to..
30 March 2026
-
AstraZeneca’s Tozorakimab Shows Str..
30 March 2026
-
Bavarian Nordic Moves to Expand Mpo..
30 March 2026
-
Can You Re-Vaccinate for RSV Effect..
27 March 2026
-
Reinventing a 90-Year-Old TB Test:..
27 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com